NMTR News and Press, 9 Meters Biopharma Inc. From 04/26/21

Scienjoy Holding Corporation SJ +29% on launching Non-Fungible Tokens on its platforms.MICT (MICT) +17%.Ocugen (OCGN) +15%.BrainsWay BWAY +14% on FDA clearance for Deep TMS protocol.China Recycling Energy (CREG) +13%.Axsome Therapeutics AXSM +12% on FDA acceptanc...

Sypris Solutions SYPR +34% on winning contract for deep space program.Silicon Laboratories SLAB +16% as Skyworks buys Infrastructure & Automotive business of the Company.LM Funding America LMFA +14% on plans to purchase up to $2.0M in digital assets.Sigma Lab...

RALEIGH, NC / ACCESSWIRE / April 21, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that management will participate in the 7 th Annual Truist Securities Life Sciences Summit and invites investors ...

What Penny Stocks Are Investors Watching Right Now? While finding penny stocks to watch might seem difficult at first, with the right research, it’s much easier than previously imagined. With so many penny stocks to buy , how can you create the best penny stock watchlist ...

Kansas City Southern (KSU) +16% on $34B bid from Canadian National.Liquid Media Group Ltd. (YVR) +13% on introduction of its NFT Platform.Obalon Therapeutics (OBLN) +11%.22nd Century Group (XXII) +10%.9 Meters Biopharma (NMTR) +8%.Fisker (FSR) +7% as BAC begins coverage with a ...

9 Meters Biopharma (NMTR) will enter into a collaboration with the Duke Clinical Research Institute to support the clinical development of 9 Meters' candidate NM-002, a proprietary long-acting GLP-1 agonist, currently in Phase 2 development for short bowel syndrome ((SBS)).9 Meters'...

RALEIGH, NC / ACCESSWIRE / April 19, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, announced today that the Company will enter into a collaboration with the Duke Clinical Research Institute (DCRI) to support the c...

RALEIGH, NC / ACCESSWIRE / April 12, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, announced today that the Company will collaborate with the Celiac Disease Foundation (CDF) to support clinical trial enrollment in...

Shares of 9 Meters Biopharma (NASDAQ: NMTR) , a clinical-stage biotech company, are trading higher on Wednesday after the company filed documents with the U.S. Securities and Exchange Commission (SEC) indicating that several of its executives have recently purchased shares of the co...

Gainers: Odonate Therapeutics (ODT) +34%, Ocugen (OCGN) +24%, Titan Medical (TMDI) +15%, Frequency Therapeutics (FREQ) +14, 9 Meters Biopharma (NMTR) +10%%.Losers: FibroGen (FGEN) -39%, Homology Medicines (FIXX) -18%, Galectin Therap...